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ABSTRACT
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Objectives: To reduce all-cause maternal and perinatal mortality and major morbidity through Lady Health
Worker (LHW)-facilitated community engagement and early diagnosis, stabilization and referral of women with
preeclampsia, an important contributor to adverse maternal and perinatal outcomes given delays in early de
tection and initial management.
Study design: In the Pakistan Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomized
controlled trial (NCT01911494), LHWs engaged the community, recruited pregnant women from 20 union
councils (clusters), undertook mobile health-guided clinical assessment for preeclampsia, and referral to facil
ities after stabilization.
Main outcome measures: The primary outcome was a composite of maternal, fetal and newborn mortality and
major morbidity.
Findings: We recruited 39,446 women in intervention (N = 20,264) and control clusters (N = 19,182) with
minimal loss to follow-up (3∙7% vs. 4∙5%, respectively). The primary outcome did not differ between inter
vention (26·6%) and control (21·9%) clusters (adjusted odds ratio, aOR, 1∙20 [95% confidence interval 0∙841∙72]; p = 0∙31). There was reduction in stillbirths (0·89 [0·81-0·99]; p = 0·03), but no impact on maternal death
(1·08 [0·69, 1·71]; p = 0·74) or morbidity (1·12 [0·57, 2·16]; p = 0·77); early (0·95 [0·82-1·09]; p = 0·46) or late
neonatal deaths (1·23 [0·97-1·55]; p = 0·09); or neonatal morbidity (1·22 [0·77, 1·96]; p = 0·40). Improvements
in outcome rates were observed with 4–7 (p = 0·015) and ≥8 (p < 0·001) (vs. 0) CLIP contacts.
Interpretation: The CLIP intervention was well accepted by the community and implemented by LHWs. Lack of
effects on adverse outcomes could relate to quality care for mothers with pre-eclampsia in health facilities.
Future strategies for community outreach must also be accompanied by health facility strengthening.
Funding: The University of British Columbia (PRE-EMPT), a grantee of the Bill & Melinda Gates Foundation
(OPP1017337).

⁎

Corresponding author at: Centre of Excellence, Division of Woman and Child Health, Aga Khan University, National Stadium Rd, Karachi, Sindh 74800, Pakistan.
E-mail address: zulfiqar.bhutta@aku.edu (Z.A. Bhutta).

https://doi.org/10.1016/j.preghy.2020.07.011
Received 6 May 2020; Received in revised form 15 July 2020; Accepted 21 July 2020
Available online 28 July 2020
2210-7789/ © 2020 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy. This is an open access
article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).

Pregnancy Hypertension 22 (2020) 109–118

R.N. Qureshi, et al.

[4]. Poor availability of transport, financial constraints, and limited
mobility of women are important additional barriers to seeking care.
In response, the government of Pakistan has invested in health
strategies and outreach services targeting poor and marginalised po
pulations. The public health sector is comprised of primary-, sec
ondary-, and tertiary-level health facilities, while the private health
sector includes informal care providers (i.e., traditional birth attendants
and spiritual healers) and formal medical clinics and/or hospitals. The
mainstay of rural primary care is a cadre of community health workers
(Lady Health Workers [8], LHWs). LHWs (currently almost 100,000)
receive formal training for 15 months including didactic course work
(3 months) and a 12-month practicum. They provide mainly maternal,
newborn and child health (MNCH) preventative services, health pro
motion and referrals, as needed, to 100–150 households, covering 70%
of the rural populations in major provinces. LHWs receive monthly

1. Introduction
The Global Burden of Disease estimates that Pakistan, the world’s
sixth most populous country, endures the world’s third highest burden
of maternal mortality (348·6/100,000 live births [95% uncertainty in
tervals (UI) 247·2-447·0]), stillbirth (27·6/1000 births [95% UI 23·132·8]), and under-five child mortality (58·0/1000 live births [95% UI
50–69]) [1,2]. In addition, Pakistan is recognised to have the highest
neonatal mortality rate globally [3].
Such adversity is associated with sociocultural factors and health
system-related barriers to accessing and receiving the best evidencebased care [4–7]. Among the barriers, delays in recognition of illness
and seeking care contributed to 36% of maternal deaths in 2006 [7].
Formative research in Sindh Province reveals the importance of hus
bands and mothers-in-law as decision makers in health care utilization

Fig. 1. Map of study area and enrollment by cluster.
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refreshers and replenishment of supplies in the primary care facilities of
respective districts. On average, as noted in external evaluation [8],
LHWs work on average five hours daily, visit an average 27 households
per week and provide advice to an average 22 clients, usually women
per week. Their current stipend is PKR 27,000 per month (US$ 173).
Pregnancy hypertension is associated with maternal and perinatal
morbidity and mortality risks worldwide, particularly in less-developed
countries like Pakistan [9]. There is a general lack of understanding by
women of the implications of having, and by health care providers of
best evidence-based care of, pregnancy hypertension [4]. The detection
and management of pregnancy hypertension is an important compo
nent of antenatal care (ANC) attendance [10]; its implementation re
flects the quality of care in pregnancy. In resource-constrained en
vironments such as Pakistan, standards against which health care
delivery is benchmarked are often basic, such as whether BP or pro
teinuria were tested at least once in pregnancy, when each of these
practices is to be delivered serially over the course of pregnancy [11].
Also, despite national policy, supplies of essential commodities (e.g.,
magnesium sulphate) are inadequate and few birthing facilities have
established protocols for eclampsia management.
A number of innovations have been tested and introduced through
the LHW programme, especially targeting perinatal and newborn care
and childhood illnesses and immunisations [12–15]. However, they
neither carry blood pressure (BP) measurement devices nor receive
training about pregnancy hypertension management.
We hypothesised that training LHWs in community engagement (to
raise awareness of, and education about, general pregnancy risks and,
specifically, pregnancy hypertension) as well as community-based as
sessment, triage, and initial treatment of pre-eclampsia would improve
maternal and perinatal outcomes. The aim of the Community-Level
Interventions for Pre-eclampsia (CLIP) cluster randomised controlled
trial (cRCT) in Sindh Province, Pakistan was to reduce maternal and
perinatal mortality and major morbidity by 20% or more in interven
tion (vs. control) clusters, through a community-level intervention to
address triage, (initial) treatment, and transport (to facility) of women
with pregnancy hypertension.

new women ended on 30 September 2016, to allow time for recruited
women to deliver by trial end on 31 December 2016.
2.2. Participants
Married pregnant women aged between 15 and 49 years were
identified by the trial surveillance teams and written informed consent
obtained for participation and quarterly data collection in surveillance
visits.
2.3. Intervention
In the intervention clusters, the CLIP intervention package consisted
of an annual group mobilisation meeting with about ten community
leaders in each village, and LHW-led visits with eligible women in their
homes, with a focus on the detection and management of pregnancy
hypertension (Fig. S1). At the first home visit and again at around seven
to eight months of pregnancy, LHWs engaged each participant herself,
in her home, along with her immediate community (e.g., mother, mo
ther-in-law, and female family or friends as she wished and were
available). Activities were supported by culturally-appropriate picto
grams developed with the LHW programme and describing maternal
and perinatal risks associated with pregnancy hypertension, as well as
awareness-raising and education about birth preparedness and com
plication readiness (e.g., prior permissions for care-seeking, transport
plans, and funding care of obstetric emergencies).
In intervention areas, the LHWs were encouraged to provide dom
iciliary visits every four-weeks (< 28 weeks), fortnightly
(28–35 weeks), weekly (≥36 weeks until birth), within 24 h of birth,
and on postpartum days 3, 7, and 14. Given the nature of tasks per
formed by LHWs, these visits were not mandated by LHW supervisors.
Tasks were guided by the tablet-based PIERS On the Move (POM)
mobile health (mHealth) application (app) [16], that included the
miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) time of disease
risk stratification [17] with pictograms as visual prompts. Altogether
223 LHWs (and associated 13 Lady Health Supervisors) were trained to
provide the CLIP intervention. The three-day didactic and participatory
training consisted of BP measurement and use of the CLIP POM tool,
with feedback and reinforcement intervention provided at regular
monthly meetings.
In brief, the POM directed LHWs to first observe women to rule out
emergency conditions (illustrated by pictograms) that would warrant
immediate referral to a facility. In the absence of emergency conditions,
LHWs were directed to measure BP twice, using standardised methods
and a semi-automated digital device validated for use in pregnancy
(Microlife BP 3AS1-2) [18]; a third measurement was required if either
the systolic or diastolic BP differed by more than 10 mmHg between the
first two readings. From January 2015 to December 2016, LHWs also
used a pulse oximeter to perform peripheral capillary oxygen saturation
(SpO2) at the first and any subsequently hypertensive visit [19].
The CLIP POM tool stratified women into one of three care path
ways: usual ante-/postnatal care, non-urgent referral to a comprehen
sive emergency obstetric care (CEmOC) or higher facility within 24 h,
or urgent referral to a CEmOC or higher facility within four hours. In
addition, women could be recommended to receive oral anti
hypertensive therapy (for severe hypertension) or intramuscular mag
nesium sulphate (for evidence of pre-eclampsia) (Fig. S1). In control
clusters, women received routine ANC provided at PHCs by nurses and
doctors and additional routine LHW domiciliary visits.
During 2015, health care providers from all secondary and tertiary,
public and private facilities in the districts received three professional
development sessions immediately prior to launching the trial and
twice during the first year, focussed on evidence-based detection and
management of pregnancy hypertension.

2. Methods
The full protocol has been published (https://clinicaltrials.gov/ct2/
show/NCT01911494; Supplementary Appendix 1), and approved by
the ethics review committees of the Aga Khan University (AKU, 2590Obs-ERC-13); University of British Columbia (UBC, H12-03497).
2.1. Study setting and trial design
The CLIP Pakistan trial was one of three independently powered
cRCTs (others in India and Mozambique; all NCT01911494), and was
conducted in Matiari and Hyderabad districts, Sindh Province, ap
proximately 150 km north of Karachi (Fig. 1). Matiari is rural and lo
cated 25 km north of Hyderabad (population: ≈600,000). Hyderabad is
semi-urban (population: ≈1,883,000; second most-populous district in
Sindh). The consistent population density is 4·7 people/hectare. The
vast majority of residents are Muslim, agriculturalists, and speak either
Sindhi and/or Urdu. Literacy rates are 40% (Matiari) to 50% (Hyder
abad). While women in the study region know about high blood pres
sure (BP) and seizures in pregnancy, they do not associate the two and
they attribute hypertension to stress or weakness [4]. They have no
Sindhi term for the most dangerous form of pregnancy hypertension,
pre-eclampsia.
The pilot phase (from 7 February 2014 to 18 January 2015), aimed
at assessing acceptability of the intervention, and transitioned to the
definitive phase (from 19 January 2015 to 31 December 2016) based on
≥50% acceptance by women of health facility referral when indicated
by the CLIP intervention (using data to 31 October 2014); no additional
outcomes were assessed at the end of the pilot phase. Recruitment of
111
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possible (e.g., WHO 2012 Verbal and Social Autopsy,[20] and trans
lated to Sindhi (local language). Data were collected initially on paper
forms (pilot phase) and then electronically using tablets (definitive
phase). Data management protocols ensured data security by encryp
tion, data tracking through user identification numbers and audit trails,
and effective data synchronisation between within-cluster devices and
the REDCap server (Vanderbilt University, USA) at UBC.

Table 1
Baseline characteristics.

Clusters
Population density (n/ha) *
Estimated annual birth rate/cluster
(n/1000)
LHWs/cluster
Neonatal mortality ratio/1000 live
births (in previous 12 months
at baseline) *
Households
Enrolled pregnancies
Nature of respondent was woman
herself
Maternal age (year) *
Married
Religion
Muslim
Hindu
Other
Women with ≥ 5 years of schooling
*
Husbands with ≥ 5 years of
schooling †
Obstetric history
Parous *
Parity
Amongst previously pregnant
women
Had previous stillbirth(s) ‡
Had previous neonatal death(s)
Delivery location in previous
pregnancy †
Home
CEmOC (hospitals)
Non-CEmOC facility
ANC care sought **
Current pregnancy
Gestational age at enrolment
(week)
Multiple pregnancy

Intervention
(n = 20,235
pregnancies)

Control
(n = 19,182
pregnancies)

10
4·1
22

10
5·3
22

21 [17,30]
27 [25·1, 36·8]

21 [13, 21.8]
28·3 [20·7, 34·1]

16,373
20,235
19,737 (97·5%)

15,569
19,182
18,612 (97·0%)

28 [25,30]
20,186 (99·8%)

28 [25,30]
19,109 (99·6%)

16,806 (83·1%)
3374 (16·7%)
18 (0·1%)
3971 (19·6%)

15,637 (81·5%)
3472 (18·1%)
5 (0·02%)
3277 (17·1%)

9532 (47·2%)

8247 (43·2%)

15,540 (77·0%)
2 [1,4] (missing
0·3%)

14,981 (78·4%)
2 [1,4] (missing
0·4%)

2368 (14·6%)
(missing 11·4%)
2318 (15·2%)
(missing 0·03%)

2276 (14·6%)
(missing 11·2%)
2263 (15·4%)
(missing 0·0%)

5051 (31·1%)
7813 (48·0%)
3342 (20·6%)
13,375 (72.5%)

5301 (34·1%)
7522 (48·4%)
2645 (17·0%)
14,153 (81.6%)

19·8 [14·1, 26·8]

20·6 [14·9, 27·4]

171 (0·8%)

182 (0·9%)

2.5. Outcomes (Panel 1)
The primary outcome was a composite of all-cause maternal, fetal,
and newborn mortality and major morbidity. Pregnancies with multiple
elements of the primary outcome were only counted once and no
weighting was used. In addition to stillbirths, maternal and newborn
deaths were estimated until 42 and 28 days after birth respectively.
Maternal morbidity consisted of serious end-organ complications that
included, but were not limited to, those related to pregnancy hy
pertension. Neonatal morbidity reflected problems related to early de
livery or delivery of a baby in poor health. All deaths, as well as sur
vived morbidities, were reviewed on a quarterly basis by an
independent panel of physicians, masked to the cluster of origin, and
excluding individuals who cared for the woman or baby under review.
The major secondary outcomes were birth preparedness and com
plication readiness, delivery in a facility able to provide emergency
obstetric care, and proportion of facility births. Other outcomes in
cluded pre-eclampsia knowledge and awareness before birth, gesta
tional age at birth, and mode of delivery.
2.6. Sample size and randomisation
Assuming an annual birth rate of 14/1000/year in each cluster, a
baseline incidence of maternal and perinatal mortality and morbidity of
9·6% in control clusters, 10% loss to follow-up, an intra-cluster co-ef
ficient (ICC) of 0·002, and a 20% reduction in all cause maternal, fetal,
and newborn morbidity and mortality, an alpha of 0·05, and 80%
power, we calculated that we would require 20 clusters over two years.
The data upon which the estimates were based on the published or
available ranges and were provided by the site investigators based on
recent surveillance data. A predetermined review of these sample size
assumptions using data from the CLIP feasibility study, pilot and defi
nitive trials was conducted independently by the statistical team (JB,
TL, HW, JS) at study midpoint.
The unit of randomisation (cluster) was a Union Council (average
population 32,000), and all associated villages and primary health
centres (PHCs). The local team chose potential clusters based on com
parability of health care infrastructure, surveillance team accessibility,
and the absence of conflicting concurrent research activity. Restricted,
stratified randomisation was undertaken according to population size.
There were 3424 possible allocations of clusters to intervention or
control, from which one was randomly selected. Two intervention and
control clusters were chosen for the pilot phase based on their im
plementation readiness.

Data presented as median [interquartile range] or number (%). * Variables used
as adjustment factors in analyses, chosen a priori. † Variable used as adjustment
factor in analyses, chosen following review of baseline data prior to knowledge
of outcomes. ‡ Not asked in pilot phase. ** ANC care sought includes only visits
with a mandated blood pressure measurement, excluding LHW CLIP contacts
and all other LHW contacts.
LHW = Lady Health Worker. CEmOC = Comprehensive emergency obstetric
care.

2.4. Baseline survey and surveillance
In intervention and control clusters, 20 LHW programme-in
dependent surveillance teams (140 individuals) were trained to un
dertake quarterly cross-sectional visits. Each team consisted of one male
team leader (chaperone) and six female data collectors who visited all
households and screened for married, pregnant women aged
15–49 years. Following informed consent, baseline individual- and
household-level data were collected (Table 1). At each visit registered
women were asked about antenatal care-seeking and birth prepared
ness, and postpartum, about adverse maternal (< 42 days postpartum),
fetal, or neonatal events (< 28 days). When maternal or perinatal
deaths were identified, an independent, experienced team was notified
to perform verbal and social autopsies.
Data collection tools were developed iteratively with local in
vestigators, derived from existing validated questionnaires where

2.7. Statistical analysis (full plan, Appendix 2)
All pregnancies, except those of women who withdrew, were in
cluded in our primary, intention-to-treat analyses. The unit of analysis
was pregnancy, classified as ‘followed-up’ (complete postpartum trial
surveillance), ‘lost-to-follow-up’ (estimated date of delivery [EDD]
at ≥ 3 weeks before trial end but without follow-up data), and ‘still-on
follow-up’ (EDD < 3 weeks before trial end).
To mitigate potential bias due to differential loss-to and incomplete
follow-up, the primary outcome of women who were lost-to, or still-on,
follow-up was imputed ten times via multiple imputation by chain
equations and Rubin’s rules [21]. Imputation models were based on all
primary analysis adjustment factors (see below) and interactions
112
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between trial arm and enrolment date (accounting for possible lag in
intervention effects). In each imputed data set, the adjusted odds ratio
(OR) for the intervention effect was estimated using a multi-level lo
gistic regression including a random intercept term for each cluster. To
improve precision, models were adjusted for variables at individual
(i.e., age, parity, maternal primary education, previous delivery loca
tions, and husband’s primary education) and cluster-level (i.e., baseline
neonatal mortality rate, LHW density, and population density). Sensi
tivity analysis including only complete cases was conducted with the
same adjustment variables.
Further, analogous multi-level logistic regression models were fit to
assess the sensitivity of the primary result to various other factors, in
cluding adjustment, missing data for a component of the primary out
come (when others were documented), gestational age at birth, and
postpartum follow-up to < 42 days, as well as cluster-level aggregate
analysis. Where sensitivity analyses included imputation, results were
pooled (Rubin’s rules) [21]. In an additional planned secondary ana
lysis, we explored within the intervention arm, whether there was a
relationship between our primary outcome and the intensity of CLIP
contacts, categorised as 0, 1–3, 4–7, or ≥8, to reflect prior and current
WHO recommendations for the frequency of antenatal contacts [22]; to
account for factors related to the number of POM-guided visit and
confounders, the analysis was adjusted for maternal age, basic educa
tion, parity, enrolment timing in the trial, and distance from the
household to facility.
All analyses were repeated for each component of the primary
outcome, albeit without imputation. Secondary and other outcomes
were compared by baseline factor-adjusted multi-level models, as
above. Statistical significance (two-sided) was set at p < 0·05 for the
primary and p < 0·01 for other analyses, without adjustment for the
interim analysis. R statistical software was used throughout.
An interim analysis was undertaken once complete data were re
ceived for women making up half of the planned sample size and re
viewed by the data safety and monitoring board (DSMB). The stopping
rule for both benefit and harm required an observed difference between
groups associated with an alpha < 0·001 (power 80%). The DSMB
reviewed all reported adverse events for participant safety.

[69·2%]). Compliance with BP measurement at all visits, and protei
nuria testing during first and all hypertensive visits, was almost uniform
(99·9% and 98·4%, respectively).
POM-guided advice for referrals, whether non-urgent (2·5% of
pregnancies) or urgent (1·4% of pregnancies), were accepted 77% of the
time. Non-urgent referral (2·5%) was for non-severe hypertension.
Urgent referral (1·4%) was most commonly for severe hypertension
(153/218, 70·2%) or absent fetal movements in the preceding 24 h (24/
218, 11·0%), and accepted 84·9% of the time. Intramuscular magne
sium sulphate (for pre-eclampsia) was recommended in 166 (0·3%) of
POM visits and accepted in 96 visits (58·3% of the time). Oral me
thyldopa (for severe hypertension) was recommended in 153 (0·3%)
visits and accepted in 148 visits (96·8% of the time). Details of the in
dications for referral according to the CLIP triggers, and LHW actions,
can be found in Table S3 and Figs. S1 and S2.
There was no significant difference in ≥4 ANC visits for women in
intervention (44·6%) vs. control (31·7%) clusters (aOR 1·84 95% CI
[0·89-3·83]; p = 0·032).
The composite primary outcome (one or more element) occurred in
more than 20% of pregnancies, related primarily to major maternal
morbidity and fetal/newborn death (≈10% each) (Table 2). The pri
mary outcome did not differ between intervention and control clusters
overall (aOR 1·20 [0·84–1·72]; p = 0·31) (Table 2), or by cluster (Table
S4). Major maternal morbidity was 37 times more common than was
maternal death (2·7/1000 identified pregnancies). Stillbirths
(≥20 weeks) and neonatal death each complicated ≈5% of pregnan
cies. Overall, there were no significant differences between the groups
for the most common major maternal morbidities (sepsis (6.8%), fol
lowed by antepartum haemorrhage (2·9%) and blood transfusion
(1·0%)). The most common major neonatal morbidity was feeding dif
ficulty (3·1%), followed by lethargy (3·0%) and hypothermia (1·8%).
There was no difference in intervention (vs. control) clusters for
birth preparedness (42·4% vs. 29·1%, respectively; aOR 2·41 [0·678·67]; p = 0·08) or pre-eclampsia knowledge and awareness (16·8% vs.
14·7%, respectively; aOR 1·11 [0·33-3·69]; p = 0·83).
Within intervention clusters, women who received both 4–7 and at
least eight POM guided contacts experienced fewer adverse outcomes
compared with women who received no contacts (28·8% (4–7) and
23·2% (≥8) vs 30·5% (0), respectively (aOR 0·89 [95% CI 0·81-0·98];
p = 0·015 and 0·66 [95% CI 0·58-0·76]; p < 0·001, respectively)
(Table 3; Fig. S3). Women with 1–3 POM-guided contacts did not have
apparent benefit compared with those without POM contacts (Table 3;
Fig. S3). Rates of stillbirth were higher in the 1–3 contact group (7·4%
vs 5·7%; aOR 1·50 [95% CI 1·24–1·82]; p < 0·001), with a trend to
more neonatal deaths (p = 0·029), compared with those receiving no
contacts (Table 3; Fig. S3).
A single adverse event was reported due to administration of the
intervention to a non-pregnant woman who had not been enrolled
(Table 4). The event was identified promptly, and trial activities paused
during steering committee review of events. The DSMB concluded that
no harm resulted from these actions.

3. Results
Between 7 February 2014 and 30 September 2016, 35,974 women
(39,417 pregnancies) were recruited in 10 intervention (20,238 preg
nancies) and 10 control (19,186 pregnancies) clusters. Of these preg
nancies, 4357 (2231 in the intervention vs. 2126 in the control arm)
were from the pilot phase. After accounting for 7 withdrawals, 20,235
and 19,182 pregnancies in intervention and control clusters, respec
tively, were included in the analysis (Fig. 2).
Pregnancies in intervention and control clusters were broadly si
milar at baseline, with most information coming directly from the
participating woman herself (Table 1, Table S2). Women were generally
in their late 20s; virtually all were married (some were either widowed
or divorced between conception and recruitment) and self-identified as
Muslim. Most had no basic education although almost half of their
husbands did. Women were generally parous and when so, reported
high rates of prior stillbirth (≈15%) and neonatal death (≈15%)
(Table S2). Few women (< 1%) had multiple pregnancies. Generally,
women were enrolled at ≈20 weeks’ gestation (Table 1).
LHW coverage varied widely between clusters (range: 9% (Odero
Lal Station) to 98% (Bhanoth)). There were 1368 community engage
ment sessions/cluster (total of 793 men’s group sessions (7784 parti
cipants) and 16,691 LHW-led sessions in pregnant women’s homes).
The visit number compliance target of 12 visits during pregnancy
and the post-natal period was met in 5723 (28.3%) pregnancies. Of the
total 58,174 visits, 10,529 women (11,399 pregnancies [56·6%]) re
ceived ≥ 1 LHW-provided POM visit, for a median of 5 [IQR 3, 7] visits
per pregnancy when received. Most visits were antenatal (40,264

4. Discussion
In the primary, pre-defined analysis, the CLIP Pakistan Trial inter
vention did not have a significant impact on either the composite
outcome of maternal, fetal, newborn mortality and severe morbidity, or
individual components thereof. This was an effectiveness trial with
functional public sector LHWs, who despite busy workloads were able
to undertake the recommended number of home visits in nearly half the
cases. The intervention was reasonably well received by families though
the overall reported morbidities detected by POM were low.
The finding of a positive effect of contact intensity of at least four
contacts, and more so with at least eight contacts, provides data to
support both the previous and current WHO recommendations.[22]
While the current WHO recommendations are based on improved
113

Pregnancy Hypertension 22 (2020) 109–118

R.N. Qureshi, et al.

Fig. 2. Trial profile – Intervention vs. control allocation clusters.

training are lacking; in retrospect, this may have limited the impact of
the CLIP intervention as CLIP data have shown that non-severe hy
pertension was predominately isolated diastolic hypertension [23]; the
advent of low-cost, validated (in pregnancy and pre-eclampsia), semiautomated BP devices has mitigated some of the BP measurement
concerns [18]. However, despite acceptance and ready application in
training programmes, the lack of impact of three technological in
novations (BP measurement device, POM and pulse oximetry) also
raises the question of the role of technology in increasing community
engagement and effectiveness of these frontline workers. The fact that
there was no impact on knowledge and awareness of pre-eclampsia and
danger signs among participating women suggests that these dom
iciliary interactions by LHWs may not have been effective. Finally,
despite recruiting almost 36,000 women (and almost 40,000 pregnan
cies), we may have been underpowered to find a difference between
trial arms as power is determined by cluster number and the betweencluster outcome rate variability was greater than anticipated (i.e., ICC
0·044).
We undertook community-ascertainment of outcomes. While mea
sures of self-reported maternal, fetal, and neonatal outcomes have been
validated in other studies [24], misreporting may have occurred. Also,
the process of community engagement may have sensitised intervention
cluster women and their families to disproportionately report adverse
events which could explain the higher reported event rates in the in
tervention clusters in the first surveillance quarter. We were unable to
use physical examination or chart review to confirm diagnoses, by
virtue of the personnel who provided care (i.e., LHWs) and the location
of that care (i.e., in the community where there is no health record).
However, to mitigate this, a group allocation-masked physician review
to adjudicate every reported maternal, fetal or newborn death or major

perinatal outcomes, our findings (vs. 0 contacts) imply both maternal
and perinatal outcomes improved (Table 3 and Fig. S2). Women with 0
contacts were likely to live closer to facilities than those with 1–3
contacts; these latter women had higher rates of fetal and neonatal
mortality. Compared with women who received 1–3 contacts, other
than maternal death and neonatal morbidity, all components of the
primary outcome were significantly reduced with at least four contacts.
Our study design and operational plan had several strengths. We
successfully engaged civil society, from women themselves, their fa
milies, faith leaders, and government ministries. Complementing the
existing health care system by task-sharing, the LHWs used the POM
mHealth platform to conduct independent antenatal and postnatal visits
and collect their findings. Our community-based data collection pro
cedures resulted in a low (< 5%) loss to follow-up despite enrolment of
nearly 40,000 pregnancies. However, including only married women
with settled addresses excluded single and internally displaced women
at higher risk of adverse outcomes; the trial was conducted following
the significant internal displacement related to the 2010 Indus River
floods.
Notwithstanding the careful design of the intervention, the effect
could have been limited by a number of factors. There were insufficient
LHWs to deliver the intervention to reach all sections of the population,
as demonstrated by < 80% of women receiving a POM visit and < 80%
compliance with the pre-specified schedule of visits when they oc
curred. The LHWs have significant tasks related to participation in the
periodic polio eradication campaigns which overall took almost a third
of their time. The annual community engagement may not have been
sufficient to induce awareness and behaviour change. We had based our
threshold for treatment and referral due to systolic hypertension to
increase generalisability where functioning sphygmomanometers and
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Table 2
Primary outcome.

Pregnancies with postpartum surveillance
Infants
Composite primary outcome†
Maternal mortality
Maternal morbidity
(including maternal deaths)
Obstetric sepsis
Antepartum haemorrhage
Blood transfusion
Stroke
Fistula
Seizure
Maternal coma
Cardiopulmonary resuscitation
Mechanical ventilation
Disseminated intravascular coagulation
Dialysis
Interventions for major postpartum haemorrhage
Perinatal mortality and late neonatal death
Stillbirth
Early neonatal death
Late neonatal death
Neonatal morbidity
Neonatal morbidity (excluding deaths)
Feeding difficulty
Lethargy
Hypothermia
Jaundice
Breathing difficulty
Seizure
Umbilical cord infection
Coma
Bleeding
Central nervous system-related morbidity
Skin infection

Intervention (n = 20,235 pregnancies)

Control (n = 19,182 pregnancies)

Adjusted OR*

p-value

18,419
18,543
5373 (26·6%)
55 (0·3%)
2196 (10·9%)

17,335
17,488
4187 (21·8%)
51 (0·3%)
1707 (8·9%)

1·20 [0·84–1·72]
1·08 [0·69–1·71]
1·12 [0·57–2·16]

0·31
0·74
0·77

1477 (7.3%)
643 (3.2%)
240 (1.2%)
58 (0.3%)
56 (0.3%)
32 (0.2%)
27 (0.1%)
11 (0.1%)
11 (0·1%)
4 (0·0%)
2 (0·0%)
2 (0·0%)
1942 (9·6%)
935 (4·6%)
819 (4·0%)
197 (1·0%)
2012 (11%)

1191 (6·2%)
487 (2·5%)
168 (0.9%)
79 (0·4%)
39 (0·2%)
18 (0·1%)
25 (0·1%)
17 (0·1%)
9 (0·0%)
8 (0·0%)
3 (0·0%)
5 (0·0%)
1906 (9·9%)
951 (5·0%)
818 (4·3%)
150 (0·8%)
1250 (7·2%)

0·95
0·89
0·95
1·23
1·22

0·22
0·03
0·46
0·09
0·40

844 (4·2%)
585 (2.9%)
405 (2.0%)
385 (1.9%)
273 (1·3%)
253 (1.3%)
284 (1·4%)
149 (0.7%)
82 (0·4%)
12 (0·1%)
2 (0·0%)

385 (2.0%)
609 (3.2%)
288 (1.5%)
389 (2.0%)
223 (1.1%)
261 (1.4%)
241 (1.3%)
109 (0.6%)
44 (0.2%)
14 (0.1%)
1 (0·0%)

[0·86–1·03]
[0·81–0·99]
[0·82–1·09]
[0·97–1·55]
[0·77–1·96]

Data presented as number (%) or number only. *Adjusted odds ratio presented as odds ratio [95% confidence interval]; adjusted for individual-level factors (maternal
age, parity, maternal education, marital status, husband’s education, delivery location), and cluster-level factors (population density, baseline study neonatal
mortality rate, healthcare worker density). † Defined as one/more of maternal morbidity or mortality, stillbirth, neonatal mortality, or neonatal morbidity.
OR = odds ratio.

morbidity, was performed. Recall bias risks were minimised by con
ducting quarterly surveillance cycles.
Our population-based estimates of maternal, fetal, and neonatal
mortality tended to be higher than those previously published for
Pakistan. Most previous estimates for Pakistan have been facility-based.
Our maternal mortality estimate was 323/100,000 livebirths (com
pared with 259 (AMANHI cohort of 31,114 pregnancies in Matiari) [25]
and 299 (secondary analysis of the WHO Multicountry Survey 2011)
[26]. For stillbirths, our estimate was 57·5/1000 livebirths (compared
with 42·8 and 27·6/1000 livebirths for Matiari and nationally, respec
tively).[2,25] Our estimate of neonatal mortality was 60·4/1000 live
births (compared with 46·9 and 55/1000 livebirths for Matiari and
nationally [Pakistan DHS 2011–12], respectively [27]. For stillbirths,
these differences may have reflected more comprehensive and accurate
ascertainment of outcomes that may have been previously misclassified
as miscarriages in the community, and that may not have come to the
attention of those providing facility-based care.
The comparability of our community-ascertained rates of morbidity
are more difficult to assess, as comparable published data are limited
and facility-based. Our incidence of maternal sepsis (7·4%) was much
higher than the recorded incidence of sepsis recorded in tertiary facil
ities in Punjab and Sindh (1·3% in all women) [28]; however, this de
finition of sepsis (comprising abortion-related infection, puerperal en
dometritis, pyelonephritis, influenza-like illness, other systemic
infections) excluded organ dysfunction whereas our broad definition of
sepsis (fever and one of: abdominal/uterine tenderness, foul smelling
vaginal discharge/lochia, productive cough and shortness of breath,

dysuria or flank pain, headache and neck stiffness) could have captured
associated complications related to organ dysfunction. The incidence of
antepartum haemorrhage in our trial (3·2%) was within the range re
ported in facility-based studies in Peshawar (3·0%) [29] or Hyderabad
(5·4%). We found no comparable regional data on population level
estimates of neonatal morbidities.
A crucial factor limiting the effect on mortality and severe morbidity
could also be the design which did not include facility-based inter
ventions and care. Our hypothesis was that implementing communitylevel evidence-based care would reduce hypertension-related (and po
tentially, all cause) maternal and perinatal mortality and major mor
bidity, by addressing the ‘three delays’ in triage, transport, and treat
ment. While we did undertake staff capacity enhancement throughout
the district, we did not specifically put measures in place to improve
quality of care. Poor-quality facility care and availability of key com
modities could have limited the beneficial effect of community-level
intervention on outcomes and negatively influenced community de
mand; perceived poor quality of care at public hospitals is a significant
barrier to seeking care [4], and health care providers in Sindh have
gaps in their knowledge about the aetiology, diagnosis, and treatment
of pre-eclampsia [6].
Finally, while the individual components of the complex CLIP in
tervention were evidence-based, how these components interacted with
one another and moderated any impact of the intervention remains
unclear but will be the subject of pre-determined secondary analyses.
The CLIP trial further confirms the ability of LHWs to task-share
important aspects of maternity care, with favourable effects on
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0·66
0·70
0·23
0·70
0·65
0·38
0·68
0·91
419 (23·2%)
177 (9·8%)
1 (0·1%)
177 (9·8%)
297 (16·4%)
50 (2·8%)
77 (4·4%)
209 (11·6%)
0·015
0·029
0·56
0·032
0·010
0·001
0·055
0·62

[0·58–0·76)
]0·57–0·85]
[0·03–1·84]
[0·58–0·87]
[0·55–0·75]
[0·28–0·52]
[0·52–0·89]
[0·75–1·09]

Adjusted OR (95% CI)†
Event rate
p

< 0·001
< 0·001
0·17
0·001
< 0·001
< 0·001
0·004
0·30

outcomes, as observed for newborns and children with other commu
nity-level interventions in Pakistan [13,30]. For example, neonatal
mortality was reduced by LHW-guided care (basic newborn resuscita
tion and identification and treatment of suspected neonatal respiratory
infections (RR 0·80 [0·68, 0·93]; p = 0·005)) [13] or LHW-led rural
group sessions focussed on promotion of antenatal care and maternal
health education, use of clean delivery kits, facility births, immediate
newborn care, identification of danger signs, and promotion of care
seeking (RR 0·85 [0·76, 0·96]; p = 0·02) [30]. Other community-level
interventions in Pakistan have noted similar non-specific temporal
improvements to those that we observed, and also highlighted the
limitation of technology- and home-based care strategies for reducing
newborn mortality when separated from facility enhancement [13].
5. Conclusions

Event rate

1726 (28·8%)
767 (12·8%)
10 (0·2%)
761 (12·7%)
1204 (20·1%)
271 (4·5%)
308 (5·4%)
742 (12·4%)

p

0·09
0·98
0·27
0·92
0·003
< 0·001
0·029
0·56

0·89
0·86
0·78
0·87
0·88
0·75
0·85
0·97

[0·81–0·98]
[0·76–0·99)
[0·33–1·81)
[0·76–0·99]
[0·79–0·97]
[0·63–0.89)
[0·72–1·00]
[0·86–1·10]

Pakistan is striving to meet global targets for the sustainable de
velopment goals to improve maternal, fetal, and newborn outcomes
while tackling the challenge of limited human resources, especially
skilled medical professionals in its rural and remote populations. This
was the genesis of our study to evaluate what could be done to mitigate
the morbidity and mortality associated with pre-eclampsia. The CLIP
Pakistan Trial demonstrates that an existing cadre of public sector
community health workers can use technology to provide accurate and
objective referral advice in pregnancy and engage and mobilize com
munities. However, as implemented, the intervention did not improve
outcomes. To achieve benefits on mortality and severe morbidity, these
efforts must be complemented with facility-based strengthening of
quality clinical care and facilitation of community-to-facility referral to
achieve maximal impact on the unacceptably-high burden of death and
morbidity in such settings.

Adjusted OR (95% CI) †

1·10 [0·99–1·23]
1.00 [0·85–1·16]
1.65 [0·68–3·98]
1.01 [0·86–1·18]
1·20 [1·06–1·35]
1·50 [1·24–1·82]
1·24 [1·02–1·51]
0·96 [0·82–1·11]
851 (33·4%)
369 (14·5%)
9 (0·4%)
367 (14·4%)
651 (25·6%)
189 (7·4%)
178 (7·5%)
343 (13·5%)

Contributors

Event rate
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Primary outcome‡
Maternal outcome
Maternal mortality
Maternal morbidity
Fetal or neonatal adverse outcome
Stillbirth
Neonatal mortality
Neonatal morbidity

Event rate

Adjusted OR (95% CI) †

1–3 visits
0 visits

Number of POM-guided visits
Outcomes

Table 3
Relationship between intensity of POM-guided CLIP contacts and the primary outcome.

4–7 visits

Adjusted OR (95% CI)†

≥8 visits

p

R.N. Qureshi, et al.
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Table 4
Secondary, safety, and other outcomes.

Secondary outcomes
Birth preparedness and complication readiness †
Proportion of facility births
Birth at a CEmOC facility
Other outcomes
Safety outcomes
SAEs unrelated to intervention
Adverse events
Transport-related injury or death
Injection site haematoma/infection after community administration of IM
MgSO4
Injection site complications after any administration of IM MgSO4
Respiratory depression, coma or death during transport following incommunity MgSO4
Maternal sBP < 110 mmHg on facility arrival following in-community
methyldopa
Deliveries (all birth outcomes)
Miscarriage**
Livebirth
Deliveries (excluding miscarriage)
Gestational age at delivery(week)
Deliveries < 37 weeks
Deliveries < 34 weeks
Missing

Intervention (n = 20,235
pregnancies)

Control (n = 19,182
pregnancies)

Adjusted OR*

p-value

8532 (42·2%)
13,517 (66·8%)
3949 (65·5%)

5580 (29·1%)
12,709 (66·3%)
3645 (68·3%)

2·41 [0·67-8.67]
0·96 [0·71-1·29]
0·9 0·60-1·34]

0·077
0·695
0·482

0 (0·0%)

0 (0·0%)

NA

NA

0/305 (0·0%)
0/73 (0·0%)

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

NA
NA

NA

NA

NA

NA

18,418
559 (3·0%)
16,943 (83·7%)
17,862
38·7 [36·0–41·0]
5475 (29·7%)
2432 (13·2%)
1112 (6·0%)

17,331
500 (2·9%)
15,913 (83·0%)
16,835
38·6 [35·7–41·0]
5543 (32·0%)
2466 (14·2%)
937 (5·4%)

–
1·10 [0·78–1·57]
1·02 [0·87–1·21]

–
0·476
0·708

0·96 [0·72–1·29]
0·93 [0·73–1·19]

0·883
0·752
0·450

Data presented as median [interquartile range] or number (%) or number only. *Odds ratio adjusted for individual-level (i.e., maternal age, parity, maternal primary
education, previous delivery locations, and husband’s primary education) and cluster-level (i.e., baseline neonatal mortality rate and population density char
acteristics). †Birth preparedness and complication readiness was defined as an answer to ALL three of the following: 1) arranged for transport, 2) obtained prior
permission to seek emergency care, and 3) saved money for obstetric care.
OR = odds ratio. CEmOC = comprehensive emergency obstetric care. sBP = systolic blood pressure.

Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.preghy.2020.07.011.
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